Galderma and Zeltiq Announce U.S. Collaboration

Galderma, a global leader in skin health, and Zeltiq Aesthetics, a medical technology company known for its CoolSculpting device, announced a new collaboration across the companies’ innovative aesthetic brands and offerings. This nationwide collaboration between two of the fastest growing companies in the aesthetic space will provide healthcare professionals and consumers with greater access to a robust range of technologically advanced and scientifically proven beauty solutions for facial rejuvenation and non-invasive fat reduction. “The collaboration between Galderma and Zeltiq is extremely exciting and will provide value to my practice and patients,” says Grant Stevens, M.D., FACS, a board-certified plastic surgeon in California. “For many years, I have used and trusted Galderma aesthetic brands and Zeltiq’s CoolSculpting. I am pleased this collaboration will result in greater access to these valuable products, as well as added benefits for my practice and patients through the ASPIRE Galderma Rewards and Crystal Rewards loyalty programs.”

In addition, the two companies will create connections between the Galderma portfolio of aesthetic brands and Zeltiq’s CoolSculpting procedure for healthcare professionals and consumers through their respective industry-leading loyalty programs: ASPIRE Galderma Rewards loyalty program (www.aspirerewards.com) and Crystal Rewards (www.coolsculpting.com). “Galderma’s aesthetic brands and Zeltiq’s CoolSculpting are some of the most popular aesthetic procedures performed in my practice,” said Jody Comstock, M.D., a board-certified dermatologist in Arizona. “This collaboration is great news for healthcare specialists and consumers alike and demonstrates Galderma’s and Zeltiq’s commitment to the aesthetics market.”

Suggested Articles

Prioritizing your own health in the weeks and months before surgery is essential for proper recovery. Here are a few doctor-recommended tips to get you…

Customer acquisition costs a lot more than customer retention. In fact, according to the Harvard Business Review, depending on what industry you’re in, “…

This week the U.S. Food and Drug Administration (FDA) announced a voluntary global recall of Allergan’s Biocell textured breast implants.